Updating your multiple-dose vial policy: The background

Hospital Pharmacy

Volumn 33, Issue 4, 1998, Pages 427-432

  Wilson, James P ^a   Cobb, Douglas Benton ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Forensic Sciences Building   (United States)

Author keywords

Expiration dating; Microbial contamination; Multidose vials; Preservatives

Indexed keywords

DRUG PRESERVATIVE;

DRUG CONTAMINATION; DRUG STABILITY; DRUG STORAGE; EXPIRATION DATE; REVIEW;

EID: 0031940121     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Sommers HM. Multiple-dosage vials. JAMA. 1962;182:1066.
2. Longfield R, Longfield J, Smith LP, et al. Multidose medication vial sterility: An in-use study and a review of the literature. Infection Control. 1984;5:165-169.
3. Santell JP. Refrigeration of used multidose vials. Am J Hosp Pharm. 1993;50: 1138.
4. Deffenbaugh JH, ed. Practice Standards of ASHP, 1996-1997. Bethesda, MD: ASHP Marketing Communications Division; 1996.
5. American Society of Hospital Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm. 1993;50:305-314.
6. American Society of Hospital Pharmacists. ASHP technical assistance bulletin on single unit and unit dose packages of drugs Am J Hosp Pharm. 1985;42:378-379.
7. ASHP Council on Professional Affairs. ASHP report: Multiple-dose vials. Am J Hosp Pharm. 1992;49:923-924.
8. Garner JS, Williams WW, Hughes JM. CDC recommendation clarified. Infection Control. 1984;5:419.
9. Longfield R, Longfield J, Smith LP, et al. Multidose medication vial sterility: An inuse study and a review of the literature. Infection Control. 1984;5:165-169.
10. Geraldine Jones, Investigation and Prevention/Hospital Division, Centers for Disease Control June 9, 1997.
11. The United States Pharmacopeial Convention. The United States Pharmacopeia XXIII. 23rd ed. Taunton, MA: Rand McNally; 1995.
12. The British Pharmacopoeial Commission. The British Pharmacopoeia 1993, Addendum 1995. London, England: HMSO Publishing; 1995.
13. Russell AD. Mechanisms of bacterial resistance to nonantibiotics: Food additives and food and pharmaceutical preservatives. J Applied Bacteriol. 1991;71:191-199.
14. Davies DJ, Richardson NE, Anthony Y. Design of a standard protocol for the challenge testing of antimicrobial preservative solutions. J Pharm Pharmacol. 1976;28: 49P.
15. Lehmann CR. Effect of refrigeration on bactericidal activity of four preserved multiple-dose injectable drug products. Am J Hosp Pharm. 1977;34:1196-1200.
16. Wahlgren S. Contamination hazards in multiple dose containers for injections. Dan Tidsskr Farm. 1970;44:1-6.
17. Turco S. Sterile Dosage Forms. 4th ed. Philadelphia, PA: Lea & Febiger; 1994.
18. Thompson GD, Thompson DF. The effect of the number of withdrawals on the sterility of multidose medication vials. J Clin Pharm Therapeut. 1992;17:61-64.
19. Akers MJ, Boand AV, Binkley DA. Preformulation method for parenteral preservative efficacy evaluation. J Pharmaceutical Sci. 1984;73:903-905.
20. Nakashima AK, Highsmith AK, Martone WJ. Survival of serratia marcescens in benzalkonium chloride and in multiple-dose medication vials: Relationship to epidemic septicarthritis. J Clin Microbiol. 1987;25: 1019-1021.
21. Morton DK, Lordi NG, Troutman LH, et al. Quantitative and mechanistic measurements of container/closure integrity: bubble, liquid, and microbial leakage tests. J Parenteral Sci Technol. 1989;43:104-108.
22. Santell JP. Expiration dating of multidose vials. Am J Hosp Pharm. 1992;49:2672-2673.
23. Heller WM. Time limits on the use of opened multiple-dose vials. Am J Hosp Pharm. 1980;37:1610.
24. Stolar MH. Multidose vials. Am J Hosp Pharm. 1980;37:185.
25. Pray WS. Small volume parenterals: ampules and vials. US Pharmacist. 1988;13:H1-H15.
26. Perceval A. Consequence of syringe-plunger contamination. Med J Austral. 1980;1:487-489.
27. Christensen EA, Mordhorst CH, Jepsen OB. Assessment of risk of microbial contamination by use of multidose containers of injectable products. J Hosp Infect. 1992;20: 301-304.
28. de Silva MI, Hood E, Tisdel E, et al. Multidosage medication vials: A study of sterility, use patterns, and cost-effectiveness. Am J Infect Control. 1986;14:135-138.
29. Bawden JC, Jacobson JA, Jackson JC, et al. Sterility and use patterns of multipledose vials. Am J Hosp Pharm. 1982;39: 294-297.
30. Kohan S, Carlin H, Whitehead R. A study of contamination of multiple-dose medication vials. Hospitals. 1962;36:79-82.
31. Bothe J. Study shows contamination in multiple-dose vials. AORN J. 1973;17: 111-114.
32. Kothari T, Reyes MP, Brooks N, et al. Pseudomonas cepacia septic arthritis due to intra-articular injections of methylprednisolone. Can Med Assn J. 1977;116: 1230-1232.
33. Sanders CV, Johanson WG, Sanford JP. Serracia marcescens infections from inhalation therapy medications: Nosocomial outbreak. Ann Int Med. 1970;73:15-20.
34. Olsen H, Frederiksen WC, Siboni KE. Flavobacterium meningosepticum in 8 nonfatal cases of postoperative bacteraemia. Lancet. 1965;1:1294-1296.
35. Stetlet HC, Dwyer DM, Orenstein WA, et al. Outbreaks of group A streptococcal abscesses following diptheria-tetanus toxoid-pertussis vaccination. Pediatrics. 1985;75:299-303.
36. Cooper CW. Prevention of HIV and HBV transmission in general practice. Med J Austral. 1993;159:339-342.
37. Harrington JF. Hepatitis B and dermatology. Med J Austral. 1994;160:525.
38. Centers for Disease Control and Prevention. Recommendations for prevention of HIV transmission in health-care settings. MMWR. 1987;36(no. 2S):1S-18S.
39. Plott RT, Wagner RF, Tyring SK. Iatrogenic contamination of multidose vials in simulated use. Arch Dermatol. 1990;126: 1441-1444.
40. Hlady WG, Hopkins RS, Ogilby TE, et al. Patient-to-patient transmission of hepatitis B in a dermatology practice. Am J Public Health. 1993;83:1689-1693.
41. Koepke JW, Reller LB, Masters HA et al. Viral contamination of intradermal skin test syringes. Ann Allergy. 1985;55:776-777.
42. Chant K, Lowe D, Rubin G, Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet. 1993;342: 1548-1549.
43. Hendricks K, Sehulster L, Bell RL, et al. Draft guideline for prevention of intravascular device-related infections. MMWR. 1996;45:285-289.
44. Oren I, Hershow RC, Ben-Porath E, et al. A common-source outbreak of fulminanthepatitis B in a hospital. Ann of Int Med. 1989;110:691-697.
45. Alter MJ, Ahtone J, Maynard JE. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. Ann Int Med. 1983;99:330-333.